Featured How has BioLineRx (BLRX) stock been impacted by COVID-19? BLRX trades on heavy volume after compelling Phase 3 Trials of Motixafortide (BL-8040) for the cancer treatment. BioLineRx Ltd. (BLRX), a clinical-stage